about
Alkali therapy attenuates the progression of kidney injury via Na/H exchanger inhibition in 5/6 nephrectomized ratsElevated baseline potassium level within reference range is associated with worse clinical outcomes in hospitalised patientsThe clinical association of the blood pressure variability with the target organ damage in hypertensive patients with chronic kidney disease.Bilirubin activates transcription of HIF-1α in human proximal tubular cells cultured in the physiologic oxygen content.Effect of bilirubin on triglyceride synthesis in streptozotocin-induced diabetic nephropathy.Effects of sodium citrate on salt sensitivity and kidney injury in chronic renal failurePredictive value of echocardiographic parameters for clinical events in patients starting hemodialysis.Role of coronary artery calcification score on the decrease in GFR among subjects with CT coronary angiography.Glomerular Hypertrophy Is a Risk Factor for Relapse in Minimal Change Disease Patients.Timing for initiation of sequential continuous renal replacement therapy in patients on extracorporeal membrane oxygenationClinical Usefulness of Unenhanced Computed Tomography in Patients with Acute PyelonephritisDifferential Signature of Obesity in the Relationship with Acute Kidney Injury and Mortality after Coronary Artery Bypass GraftingVolumE maNagement Under body composition monitoring in critically ill patientS on CRRT: study protocol for a randomized controlled trial (VENUS trial)Short-term and long-term effects of low serum bicarbonate level at admission in hospitalised patientsSerum resistin as a novel marker of erythropoietin resistance in nondiabetic patients on hemodialysisOptimal systolic blood pressure in noncritically ill patients with acute kidney injury: A retrospective cohort study
P50
Q33627529-8CE8E1BD-4C61-42C2-B971-FE20A644B157Q33729193-CEBA5BD5-9B32-4AA7-890F-82D955E30A69Q33913736-D3B3E3D8-6F8D-4800-913B-D1A439287415Q34325393-A30C164E-4B2A-41E0-856E-4B8F57D31B8EQ34325399-5D66269E-D2BE-46D3-9A84-543E0EEE676FQ34591949-0FF545B1-BE17-4400-801C-A8EA031580B0Q34779472-99E04AA2-55A4-481A-A65D-F251C953D433Q51174148-99F21C21-C9D8-443D-90C9-1EF8972EBF34Q53252577-F5CE2B60-A338-4415-9CBB-D2EE03805699Q58795399-E1C9F3E7-9730-4667-9883-8AE467FD9EFAQ58804349-106F2029-CF45-4396-B8DC-7E1F5156A14DQ59339656-885AA8FC-B514-4237-81AA-E749A38AF550Q60045605-479DBBBB-AA21-4C50-ADC5-D1699DF075A2Q64103210-87CF6DC3-160E-4727-966D-BD2BCC93B970Q84583111-87053DC9-5E00-4CE7-AD35-FB4A35AA7091Q93041564-179DE53C-3DB9-4950-AF53-1E648691B70B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sejoong Kim
@ast
Sejoong Kim
@en
Sejoong Kim
@es
Sejoong Kim
@nl
Sejoong Kim
@sl
type
label
Sejoong Kim
@ast
Sejoong Kim
@en
Sejoong Kim
@es
Sejoong Kim
@nl
Sejoong Kim
@sl
prefLabel
Sejoong Kim
@ast
Sejoong Kim
@en
Sejoong Kim
@es
Sejoong Kim
@nl
Sejoong Kim
@sl
P1053
D-5581-2012
J-5356-2015
P106
P31
P3829
P496
0000-0002-7238-9962